Schedule‐dependent therapeutic efficacy of L19m TNF ‐α and melphalan combined with gemcitabine

Author:

Mortara Lorenzo1,Orecchia Paola2,Castellani Patrizia3,Borsi Laura3,Carnemolla Barbara4,Balza Enrica3

Affiliation:

1. Department of Biotechnology and Life Sciences University of Insubria Varese Italy

2. Department of Experimental Medicine University of Genoa Genova Italy

3. Department of Translational Oncology Laboratory of Cell Biology IRCSS AOU San Martino‐Istituto Nazionale per la Ricerca sul Cancro Genova Italy

4. Department of Translational Oncology Laboratory of Immunology IRCSS AOU San Martino‐Istituto Nazionale per la Ricerca sul Cancro Genova Italy

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference39 articles.

1. The fibronectin isoform containing the ed-b oncofetal domain: A marker of angiogenesis

2. Differentiation between High- and Low-Grade Astrocytoma Using a Human Recombinant Antibody to the Extra Domain-B of Fibronectin

3. A high affinity human antibody that targets tumoral blood vessels;Tarli L.;Blood,1999

4. Immunoscintigraphic detection of the ED‐B domain of fibronectin, a marker of angiogenesis, in patients with cancer;Santimaria M.;Clin. Cancer Res.,2003

5. Toxic effect of tumor necrosis factor on tumor vasculature in mice;Watanabe N.;Cancer Res.,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3